Skip to content

Clinical evaluation of the efficacy and safety of Luxiva brand skin mesotherapy solution for rejuvenation of facial skin

Clinical evaluation of the efficacy and safety of Luxiva brand skin mesotherapy solution for rejuvenation and improvement of facial skin elasticity and hydration

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150101020514N25
Enrollment
20
Registered
2023-11-12
Start date
2023-11-22
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin hydration.

Interventions

Intervention group: 4 sessions with 4 cc sterile solution of Luxiva injection mesotherapy. The intervals for the first three injections are done at the beginning of every two weeks and the fourth inje

Sponsors

Atra Zist Arai Company
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 35 and 60 years old Present visible signs of skin ageing symptoms mainly skin dryness skin roughness, loss of elasticity and appearance of fine lines Possibility to accompany the visit plans and study process. Signing an informed consent form and agreed to follow up.

Exclusion criteria

Exclusion criteria: Previous treatment with hyaluronic acid fillers in the facial area within the past year Experience with RF, rejuvenation lasers or intense pulsed light in the past 6 months Systemic diseases affecting skin health such as collagen vascular diseases, diabetes, hypothyroidism, as well as liver and renal failure. History of systemic use of skin-related medicine such as glucocorticoids, isotretinoin, immunomodulators and hormonal medicine in the past 3 months Currently pregnant or lactating Smoking in the past two years

Design outcomes

Primary

MeasureTime frame
Skin elasticity. Timepoint: Before intervention, one month after the last injection (day 90) and 2 months after the last injection (day 120). Method of measurement: Cutometery.

Secondary

MeasureTime frame
Stratum corneum hydration. Timepoint: Before intervention, one month after the last injection (day 90) and 2 months after the last injection (day 120). Method of measurement: Corneometry by MPA 580.;Skin condition for signs of skin aging including clear lines and wrinkles. Timepoint: Before intervention, one month after the last injection (day 90) and 2 months after the last injection (day 120). Method of measurement: Using GAIS scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAniseh Samadi

Tehran University of Medical Sciences

aniseh_samadi@yahoo.com+98 21 8896 0880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026